Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Read more about Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Read more about Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer.
The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland. Read more about The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Read more about Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas.
Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Read more about Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence.
Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures. Read more about Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.
Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Read more about Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer.
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Read more about Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
Abdominal organ motion measured using 4D CT. Read more about Abdominal organ motion measured using 4D CT.
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Read more about Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer.
